MPM BioImpact’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-552,846
| Closed | -$4.94M | – | 34 |
|
|
2023
Q3 | $4.94M | Hold |
552,846
| – | – | 1.32% | 25 |
|
|
2023
Q2 | $8.49M | Buy |
552,846
+239,204
| +76% | +$3.67M | 1.71% | 19 |
|
|
2023
Q1 | $7.05M | Buy |
313,642
+31,931
| +11% | +$718K | 1.83% | 15 |
|
|
2022
Q4 | $5.92M | Buy |
281,711
+5,251
| +2% | +$110K | 1.54% | 18 |
|
|
2022
Q3 | $6.81M | Sell |
276,460
-1,490
| -0.5% | -$36.7K | 1.61% | 17 |
|
|
2022
Q2 | $6.74M | Hold |
277,950
| – | – | 1.87% | 14 |
|
|
2022
Q1 | $7.16M | Sell |
277,950
-9,943
| -3% | -$256K | 1.92% | 14 |
|
|
2021
Q4 | $8.94M | Sell |
287,893
-18,622
| -6% | -$578K | 1.63% | 16 |
|
|
2021
Q3 | $7.43M | Buy |
+306,515
| New | +$7.43M | 1.15% | 20 |
|